Kissei Pharmaceutical Co (TSE:4547) DeferredTaxAndRevenue: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4547 Kissei Pharmaceutical Co Ltd TSE:4547
79 GF Score
Price 円3,860.00
GF Value 円4,688.48
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co DeferredTaxAndRevenue?

Kissei Pharmaceutical Co TSE:4547 +0.13% 79 DeferredTaxAndRevenue is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:4547 with a GF Score™ of 79/100 and a GF Value™ of 円4,688.48 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Kissei Pharmaceutical Co's current deferred tax and revenue for the quarter that ended in Mar. 2026 was 円0 Mil.

Kissei Pharmaceutical Co DeferredTaxAndRevenue Related Terms

Kissei Pharmaceutical Co DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Kissei Pharmaceutical Co's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co DeferredTaxAndRevenue Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kissei Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4547
79GF Score
Kissei Pharmaceutical Co Ltd TSE:4547
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of 円0 Mil mean?
Kissei Pharmaceutical Co (TSE:4547) has a DeferredTaxAndRevenue of 円0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Kissei Pharmaceutical Co.
Is Kissei Pharmaceutical Co's DeferredTaxAndRevenue too high?
Kissei Pharmaceutical Co's current DeferredTaxAndRevenue is 円0 Mil. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's DeferredTaxAndRevenue compare to ZTS?
Kissei Pharmaceutical Co's DeferredTaxAndRevenue of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Kissei Pharmaceutical Co. Kissei Pharmaceutical Co's current DeferredTaxAndRevenue is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kissei Pharmaceutical Co (TSE:4547) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,688.48, compared to a current price of 円3,860.00 — trading 17.7% below its estimated fair value. The current DeferredTaxAndRevenue is 円0 Mil. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Kissei Pharmaceutical Co (TSE:4547), the current DeferredTaxAndRevenue is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kissei Pharmaceutical Co (TSE:4547) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,860.00 is trading 17.7% below its estimated GF Value™ of 円4,688.48. GuruFocus considers Kissei Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4547:

  • DeferredTaxAndRevenue: 円0 Mil
  • GF Value™: 円4,688.48 vs. price of 円3,860.00 (17.7% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the TSE:4547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kissei Pharmaceutical Co Business Description

Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score

Get the complete analysis for TSE:4547

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,860.00
Price
円4,688.48
GF Value